Summary
- Current Price
- As of today, PCRX price is $36.39, up +44.40% on
- Current Price All-Time High
- PCRX price is currently -70.16% below its historical high of $121.95 set on
- Market Cap
- PCRX current market cap is $1B, up +42.36% over the past 365 days
- PE Ratio
- PCRX current PE ratio is 104.84
- Revenue
- PCRX current annual revenue is $726.41M, up +3.63% year-over-year
- Next Earnings
- The next earnings release for PCRX is on
Profile
| Metric | Value |
|---|---|
| Full Name | Pacira BioSciences, Inc. |
| Ticker | NASDAQ: PCRX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Specialty & Generic Drug Manufacturers |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | pacira.com |
| Employees | 788 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $36.39 | |
| Price, 1D Change | +44.40% | |
| $1B | ||
| - | ||
| 104.84 | ||
| 0.16 | ||
| $726.41M | ||
| Revenue, 1Y Change | +3.63% | |
| $0.16 | ||
| EPS, 1Y Change | +107.26% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| $0.16 | ||
| EPS Estimate | $2.89 | N/A |
| EPS Est. Change | +1,750.45% | N/A |
| $726.41M | ||
| Revenue Estimate | $754.36M | N/A |
| Revenue Est. Change | +3.85% | N/A |
| Current Price | $36.39 | |
| Price Target | $30.00 | - |
| Price Tgt. Change | -17.56% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $3.15 | -$2.15 | -168.33% | |
| $2.95 | $0.16 | -94.71% | |
| $2.89 | N/A | +1,750.45% | |
| $3.44 | N/A | +2,103.71% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $700.50M | $700.97M | +0.07% | |
| $731.56M | $726.41M | -0.70% | |
| $754.36M | N/A | +3.85% | |
| $789.70M | N/A | +8.71% |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $36.39 | |
| $23.93 | ||
| $25.38 | ||
| $24.47 | ||
| $25.51 | ||
| $0.87 | ||
| 0.16 | ||
| $1.57 | ||
| 85.07 | ||
| 224.63% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $726.41M | ||
| $0.16 | ||
| $0.00 | ||
| 71.50% | ||
| $28.10M | ||
| 3.87% | ||
| $7.03M | ||
| 0.97% | ||
| $119.13M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.60 | ||
| 4.54 | ||
| 3.28 | ||
| - | ||
| 9 | ||
| 2.26 |
Valuations
| Metric | Value | Date |
|---|---|---|
| 104.84 | ||
| 1.92 | ||
| 2.13 | ||
| 14.12 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $693.11M | ||
| $238.42M | ||
| $1.26B | ||
| $547.97M | ||
| $571.81M | ||
| $120.59M | ||
| $418.20M | ||
| $9.84M | ||
| $15.15M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $719.38M | ||
| $491.27M | ||
| $207.04M | ||
| $326.89M | ||
| $91.02M | ||
| $0.00 | ||
| $9.84M |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| $151.99M | ||
| $99.48M | ||
| -$369.63M | ||
| $15.33M | ||
| $136.66M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Oppenheimer | ||
| Leerink Partners | ||
| RBC Capital | → | |
| Needham | → | |
| HC Wainwright & Co. | → | |
| RBC Capital | → | |
| Needham | → | |
| Barclays | → | |
| Needham | → | |
| HC Wainwright & Co. | → |
Analyst sentiment
Institutional ownership
No data
Screeners with PCRX
FAQ
- What is the ticker symbol for Pacira BioSciences, Inc.?
- The ticker symbol for Pacira BioSciences, Inc. is NASDAQ:PCRX
- Does Pacira BioSciences, Inc. pay dividends?
- No, Pacira BioSciences, Inc. does not pay dividends
- What sector is Pacira BioSciences, Inc. in?
- Pacira BioSciences, Inc. is in the Healthcare sector
- What industry is Pacira BioSciences, Inc. in?
- Pacira BioSciences, Inc. is in the Specialty & Generic Drug Manufacturers industry
- What country is Pacira BioSciences, Inc. based in?
- Pacira BioSciences, Inc. is headquartered in United States
- When did Pacira BioSciences, Inc. go public?
- Pacira BioSciences, Inc. initial public offering (IPO) was on February 3, 2011
- Is Pacira BioSciences, Inc. in the S&P 500?
- No, Pacira BioSciences, Inc. is not included in the S&P 500 index
- Is Pacira BioSciences, Inc. in the NASDAQ 100?
- No, Pacira BioSciences, Inc. is not included in the NASDAQ 100 index
- Is Pacira BioSciences, Inc. in the Dow Jones?
- No, Pacira BioSciences, Inc. is not included in the Dow Jones index
- When was Pacira BioSciences, Inc. last earnings report?
- Pacira BioSciences, Inc.'s most recent earnings report was on August 4, 2026
- When does Pacira BioSciences, Inc. report earnings?
- The next expected earnings date for Pacira BioSciences, Inc. is November 5, 2026
Data Sources & References
- PCRX Official Website www.pacira.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1396814/000162828026012297/0001628280-26-012297-index.htm
- PCRX Profile on Yahoo Finance finance.yahoo.com/quote/PCRX
- PCRX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/pcrx
